title: Assessment of myocardial viability in a reperfused porcine model: evaluation of different MSCT contrast protocols in acute and subacute infarct stages in comparison with MRI.
abstract: OBJECTIVE
  To assess myocardial viability in acute and subacute infarcts using different multislice spiral computed tomography contrast protocols with magnetic resonance imaging (MRI) correlation.
  
  
  METHODS
  Seven pigs were studied with 64-multislice spiral computed tomography and MRI (1.5 T) at a median of 1 and 21 days after temporary occlusion of the second diagonal branch. Computed tomography was performed at 3, 5, 10, and 15 minutes after injection of contrast medium. Contrast agent was applied either as a bolus (protocol 1; n = 7 for the first; n = 5 for the second scan) or as a bolus plus 30 mL of subsequent 0.1 mL/s low-flow (protocol 2; n = 7 for the first; n = 6 for the second scan). Finally, histological sections were obtained. Volumes of infarcted myocardium were assessed as the percentage of the left ventricle. Computed tomography attenuation values were obtained, and image quality was assessed.
  
  
  RESULTS
  When compared with protocol 1, protocol 2 provided greater Hounsfield unit attenuation difference between viable and nonviable myocardium at 5, 10, and 15 minutes (P = 0.19; 0.003; 0.0006) and an additional significant contrast between nonviable myocardium and ventricular blood at 3 and 5 minutes (P < 0.001). Image quality was rated significantly higher with the use of protocol 2 at 5, 10, and 15 minutes (P < or = 0.027) and for all time points use of protocol 2 resulted in improved correlation of acute and subacute infarct size with MRI.
  
  
  CONCLUSIONS
  Good correlation of infarct zones with MRI was achieved for both acute and subacute infarcts. With the use of a bolus/low-flow protocol, image quality was substantially improved by means of a higher tissue contrast.
authors.affiliation: Department of Diagnostic Radiology, Eberhard-Karls-University, Tübingen, Germany. hbrodoefel@t-online.de
authors.forename: Harald
authors.initials: H
authors.lastname: Brodoefel
authors.forename: Anja
authors.initials: A
authors.lastname: Reimann
authors.forename: Bernhard
authors.initials: B
authors.lastname: Klumpp
authors.forename: Michael
authors.initials: M
authors.lastname: Fenchel
authors.forename: Martin
authors.initials: M
authors.lastname: Ohmer
authors.forename: Stephan
authors.initials: S
authors.lastname: Miller
authors.forename: Stephen
authors.initials: S
authors.lastname: Schroeder
authors.forename: Claus
authors.initials: C
authors.lastname: Claussen
authors.forename: Albertus
authors.initials: A
authors.lastname: Scheule
authors.forename: Andreas F
authors.initials: AF
authors.lastname: Kopp
mesh_terms: D000208:Acute Disease; D000704:Analysis of Variance; D000818:Animals; D003287:Contrast Media / Q000008:administration & dosage*; D003326:Coronary Circulation; D004195:Disease Models, Animal; D005240:Feasibility Studies; D007089:Image Enhancement / Q000379:methods; D007479:Iopamidol / Q000031:analogs & derivatives; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000473:pathology; D015425:Myocardial Reperfusion / Q000379:methods*; D009206:Myocardium / Q000473:pathology*; D015203:Reproducibility of Results; D013552:Swine; D013997:Time Factors; D036542:Tomography, Spiral Computed / Q000379:methods*
chemical_list: D003287:Contrast Media; C057937:iomeprol; D007479:Iopamidol